Skip to Main Content

Paper Details

The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age.
Semin Nephrol
43
2020
ICI, RCC, Renal Cell Carcinoma, anti, anti-programmed cell death protein 1, clear, clear cell RCC, cytotoxic T-, interferon-, interleukin 2, kidney tumor, mammalian target of rapamycin complex 1, metastatic RCC, patients, programmed death-ligand 1, rapamycin, renal carcinoma, renal cell carcinoma, tyrosine, tyrosine kinase, vascular endothelial growth factor receptor 2
Author NameAffiliation
James J HsiehSiteman Cancer Center, Washington University
James J HsiehSiteman Cancer Center, Washington University
  • 1 - 2

Datasets

Release 1.2